. Densitometric analysis of RGS4 and xCT protein levels in organotypic brain-slice cultures with or without RGS4 knockdown or RGS4 overexpression (n = 9 samples). The density of proteins in each control (untreated) group was used as a standard (1 arbitrary unit) to compare relative densities in the other groups. *P < 0.001 compared to control groups, Two-way ANOVA followed by Bonferroni test. Figure S2 . Ex vivo biodistribution of 18 F-labelled alkylthiophenyl guanidine ( 18 F-FSAG, a specific radioligand for PCP sites of the NMDAR) in the microinjection sites at 21 days after virus injection. Before biodistribution studies, mice were pre-treated with NAC (500 mg/kg/day) or vehicle for 1 week. N=8 per group. *P < 0.01 compared to control mice; # P < 0.05 compared to vehicle-treated mice, one-way ANOVA followed by Tukey test. Figure S3 . There is no significance between RGS4 knockdown mice and control mice in prefrontal cortical glutathione (GSH) content. GSH assay was carried out at 21 days after virus injection. For the NAC treatment, mice were pre-treated with NAC (500 mg/kg/day) or vehicle for 1 week before GSH assay. N=9 per group. 
